Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-07-01FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUVIA (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2019-07-01FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRADJENTA (linagliptin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2019-07-01FDA Approved: KAZANO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for KAZANO, a fixed-dose combination of alogliptin and metformin hydrochloride, by Takeda Pharma…
-
FDA approval · 2019-07-01FDA Approved: JENTADUETO XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO XR (linagliptin and metformin hydrochloride) submitted by Boehringer Ingelheim Ph…
-
FDA approval · 2019-07-01FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharmaceu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 Diabetes [NA]
Clinical trial update on the efficacy of Glucerna SR in Chinese drug-naïve subjects with type 2 diabetes; study completed with results poste…
-
CLINICAL_TRIALS research · 2019-07-01Clinical Trial Update: Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes [Phase 4]
Phase 4 clinical trial assessing how dietary factors influence the glucose-lowering effects of sitagliptin in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions [NA]
Clinical trial evaluating a white sweet potato tube feeding formula in long-term care residents with type 2 diabetes has completed; results …
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST) [Phase 4]
A Phase 4 trial investigating the effect of a GLP-1 agonist on liver steatosis in adults with type 2 diabetes and nonalcoholic steatohepatit…
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy [Phase 4]
Phase 4 trial evaluating the effect of Cycloset added to GLP-1 analogue therapy on glycemic control in adults with type 2 diabetes.
-
FDA approval · 2019-06-20FDA Approved: MYXREDLIN — Original Application (Baxter Healthcare Corporation)
FDA approved MYXREDLIN (insulin human) from Baxter Healthcare Corporation through an original application for use in the treatment of diabet…
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes [Phase 4]
A Phase 4 randomized controlled pilot study evaluating safety and efficacy of Exenatide (Byetta) for inpatient management of Type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: A Study of LY2881835 in Healthy People and People With Diabetes [Phase 1]
Phase 1 trial update for LY2881835 in healthy individuals and people with type 2 diabetes; study completed with results posted.
-
FDA label_change · 2019-06-17FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for liraglutide from Teva Pharmaceuticals USA, Inc., resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas [Phase 4]
A Phase 4 trial comparing the renal effects of DPP-4 inhibitors versus sulfonylureas in type 2 diabetes patients with proteinuria has comple…
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Vortioxetine vs Sertraline in Mexicans [Phase 4]
Phase 4 trial comparing vortioxetine to sertraline in Mexican patients with depression and type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period [Phase 3]
Phase 3 trial comparing an insulin glargine/lixisenatide fixed-ratio combination to a GLP-1 receptor agonist in type 2 diabetes, with an ext…
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy [Phase 2]
A Phase 2 trial evaluated closed-loop glucose control (artificial pancreas) for 24 hours in adults with Type 2 diabetes on intensive insulin…
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial update examining the effects of replacing Lantus with Basalin on glycemic variation in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes [Phase 4]
A Phase 4 trial assessing 13 weeks of add-on vildagliptin to improve glucose variability in type 2 diabetes, trial terminated.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: An Extension Study of PEAK Trial [Phase 4]
Extension study update for a Phase 4 trial in type 2 diabetes mellitus; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD [Phase 2, Phase 3]
A Phase 2/3 trial evaluating dapagliflozin with and without saxagliptin on albuminuria and HbA1c in patients with type 2 diabetes and chroni…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Effects of Structured Simplified Short-term Intensive Insulin Therapy on Long-term Glycemic Remission [Phase 4]
Phase 4 clinical trial evaluating structured simplified short-term intensive insulin therapy for long-term glycemic remission in newly diagn…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: A Study of LY2922470 in Healthy Participants and Participants With Diabetes [Phase 1]
Phase 1 study of LY2922470 in healthy participants and individuals with Type 2 diabetes has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients [NA]
Clinical trial assessing home food environment and diabetes self-management among adults with Type 2 diabetes has completed; results posted …